Percy H. Carter
Chief Scientific Officer · Blueprint Medicines Corp
- 2025
- Jul 17, 2025
- 2
Other insiders active in the same stocks
Insiders who have reported open-market trades at the same companies as Percy H. Carter. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Lonnel Coats - $1.87M in BPMC purchases and sales on record
- Jeffrey W. Albers - $1.86M in BPMC purchases and sales on record
- Christina Rossi - $585K in BPMC purchases and sales on record
- Fouad Namouni - $324K in BPMC purchases and sales on record
- Kate Haviland - $227K in BPMC purchases and sales on record
- Ariel Hurley - $170K in BPMC purchases and sales on record
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Percy H. Carter?
Percy H. Carter is a corporate insider, tracked as Chief Scientific Officer of Blueprint Medicines Corp (BPMC). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Percy H. Carter last file a Form 4?
The most recent primary Form 4 on record is dated 17 July 2025, one of 2 filings going back to 2025.
Has Percy H. Carter been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($135K) across all tracked filings.
